FI773786A - Foerfarande foer framstaellning av nya terapeutiskt aktiva piperazinderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt aktiva piperazinderivat

Info

Publication number
FI773786A
FI773786A FI773786A FI773786A FI773786A FI 773786 A FI773786 A FI 773786A FI 773786 A FI773786 A FI 773786A FI 773786 A FI773786 A FI 773786A FI 773786 A FI773786 A FI 773786A
Authority
FI
Finland
Prior art keywords
framework
therapeutic treatment
active therapy
therapy
active
Prior art date
Application number
FI773786A
Other languages
English (en)
Other versions
FI69839C (fi
FI69839B (fi
Inventor
Johan Gootjes
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of FI773786A publication Critical patent/FI773786A/fi
Application granted granted Critical
Publication of FI69839B publication Critical patent/FI69839B/fi
Publication of FI69839C publication Critical patent/FI69839C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI773786A 1976-12-14 1977-12-14 Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat FI69839C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB52223/76A GB1545094A (en) 1976-12-14 1976-12-14 Piperazine derivatives
GB5222376 1976-12-14

Publications (3)

Publication Number Publication Date
FI773786A true FI773786A (fi) 1978-06-15
FI69839B FI69839B (fi) 1985-12-31
FI69839C FI69839C (fi) 1986-05-26

Family

ID=10463103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773786A FI69839C (fi) 1976-12-14 1977-12-14 Foerfarande foer framstaellning av terapeutiskt aktiva difenylmetoxialkylpiperazinderivat

Country Status (22)

Country Link
US (2) US4202896A (fi)
JP (1) JPS5382789A (fi)
AT (1) AT363090B (fi)
AU (1) AU516920B2 (fi)
BE (1) BE861853A (fi)
DE (1) DE2755752A1 (fi)
DK (1) DK147421C (fi)
ES (6) ES465047A1 (fi)
FI (1) FI69839C (fi)
GB (1) GB1545094A (fi)
HU (1) HU177999B (fi)
IE (1) IE46278B1 (fi)
IL (1) IL53597A0 (fi)
IT (1) IT1093045B (fi)
LU (1) LU78686A1 (fi)
NL (1) NL7713817A (fi)
NO (1) NO148150C (fi)
NZ (1) NZ185981A (fi)
PT (1) PT67400B (fi)
SE (1) SE435378B (fi)
YU (1) YU295877A (fi)
ZA (1) ZA777452B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981003658A1 (en) * 1980-06-16 1981-12-24 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
NL8202636A (nl) * 1982-06-29 1984-01-16 Gist Brocades Nv Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
DE3600390A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5162537A (en) * 1986-04-17 1992-11-10 Monsanto Company Benzhydryl compounds as herbicide antidotes
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
HU196196B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
FR2636946B1 (fr) * 1988-09-23 1990-11-02 Lipha ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
US5087627A (en) * 1989-03-15 1992-02-11 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
US5153198A (en) * 1989-03-15 1992-10-06 Santen Pharmaceutical Co., Ltd. Agent for treatment of disorders of the cerebro-neural transmission system
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
DK178490D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
PT706796E (pt) * 1993-06-25 2001-06-29 Pola Chem Ind Inc Inibidor de reincorporacao de dopamina
ATE407124T1 (de) * 2000-01-11 2008-09-15 Molecular Insight Pharm Inc Polypharmacophore verbindungen
US6743797B2 (en) 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20050054010A1 (en) * 2003-07-15 2005-03-10 Brown Arthur M. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US7211407B2 (en) * 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
US20050208595A1 (en) * 2004-03-19 2005-09-22 Brown Arthur M High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
RU2499795C2 (ru) 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
JP2009537596A (ja) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー ６−（４−シクロプロピルピペリジン−１−イル）−２’−メチル−［３，４’］−ビピリジン及びその医薬としての使用
WO2007137968A1 (en) * 2006-05-29 2007-12-06 High Point Pharmaceuticals, Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US20120028992A1 (en) * 2010-08-02 2012-02-02 Brown Arthur M Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
CN104529942B (zh) * 2014-12-10 2018-05-15 天津孚音生物科技发展有限公司 一种伐诺司林的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB837986A (en) 1956-07-10 1960-06-22 Henri Morren New piperazine derivatives and process for the preparation thereof
US2953568A (en) * 1958-03-03 1960-09-20 Ciba Pharm Prod Inc Derivatives of piperazine
CH410961A (de) * 1961-02-22 1966-04-15 Yoshitomi Pharmaceutical Verfahren zur Herstellung N-substituierter Piperazinderivate
DE1445692A1 (de) 1963-03-25 1969-03-20 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Piperazinderivaten
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
JPS504086A (fi) * 1973-01-18 1975-01-16

Also Published As

Publication number Publication date
SE435378B (sv) 1984-09-24
PT67400A (en) 1978-01-01
JPS5382789A (en) 1978-07-21
IE46278L (en) 1978-06-14
NZ185981A (en) 1980-02-21
GB1545094A (en) 1979-05-02
JPS6215546B2 (fi) 1987-04-08
NL7713817A (nl) 1978-06-16
AT363090B (de) 1981-07-10
AU3157377A (en) 1979-06-21
ES473817A1 (es) 1979-04-16
IT1093045B (it) 1985-07-19
DE2755752C2 (fi) 1991-12-05
FI69839C (fi) 1986-05-26
ES473818A1 (es) 1979-04-16
BE861853A (fr) 1978-06-14
ES473816A1 (es) 1979-04-16
AU516920B2 (en) 1981-07-02
ATA891177A (de) 1980-12-15
YU295877A (en) 1983-01-21
PT67400B (en) 1979-05-21
DK557277A (da) 1978-06-15
LU78686A1 (fi) 1978-04-17
DK147421B (da) 1984-07-30
HU177999B (en) 1982-02-27
ES465047A1 (es) 1979-01-01
IE46278B1 (en) 1983-04-20
NO148150C (no) 1983-08-24
SE7714184L (sv) 1978-06-15
ES473815A1 (es) 1979-05-01
ES473814A1 (es) 1979-04-16
NO148150B (no) 1983-05-09
DE2755752A1 (de) 1978-06-15
US4202896A (en) 1980-05-13
NO774307L (no) 1978-06-15
DK147421C (da) 1985-02-11
US4265894A (en) 1981-05-05
IL53597A0 (en) 1978-03-10
ZA777452B (en) 1978-10-25
FI69839B (fi) 1985-12-31

Similar Documents

Publication Publication Date Title
FI773786A (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva piperazinderivat
FI65777B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara erolinderivat
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
SE7800303L (sv) Proktologisk anordning for terapeutisk behandling av hemorroider
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
SE7601204L (sv) Terapeutiskt system for administrering av skopolamin transdermalt
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO147750C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive og optisk aktive 11-desoksy-16-aryloksy-omega-tetranorprostaglandiner
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
SE7601894L (sv) Terapeutiskt medel
SE7704309L (sv) Bestralningsapparat for behandling av hudsjukdomar
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO152556C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner
NO144019C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridinderivater
NO145656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
NO145538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-forbindelser
NO146061C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive derivater av 2-iminothiazolidiner og 2-iminothiazoliner
NO143969C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-cyanoalkyl-p-halogenfenoksy-isobutyramider

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BROCADES PHARMA B. V.